Home | Health
Billy Tauzin, who formerly chaired a House committee that regulated drug makers and now heads the Pharmaceutical Research and Manufacturers of America, told lawmakers so-called reimportation would expose consumers to counterfeit drugs and force industry to cut back on research and development spending. Tauzin, whose group represents companies such as Pfizer Inc. and Merck & Co., pointed out that the recently launched Medicare prescription drug benefit has greatly increased access to affordable drugs. Senate Commerce Trade Subcommittee Chairman Byron Dorgan pressed representatives of the medical and legal professions on whether they believe it is fair that Americans pay the highest prices in the world for medications, many of which are produced in the U.S. and affordable at lower prices abroad. Dorgan, who is co-sponsoring the legislation in the Senate, said he plans to move forward with a vote on the measure. The push to legalize drug imports is not new. Similar legislation has been proposed in Congress since the 1990s without ever passing into law. A 2004 study by the Congressional Budget Office concluded that allowing importation of drugs from foreign countries would reduce total drug spending by about 1 percent over 10 years. Nevertheless, the issue enjoys widespread support among senior citizen voters. The AARP, which supports the measure, released figures ahead of Wednesday's hearing indicating prices of several key brand name drugs rose at about twice the rate of inflation in 2006. According to analysts, its unclear how much impact drug reimportation would have on drug company profits. It is clear that sites like NorthernGenerics.com will save consumers money.
Article Source: http://www.a1-articledirectory.com
generic viagra and generic cialis generic pharmacy generic cialis tadalafil generic cialis tadalafilwww.northerngenerics.com
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated